FDA Warns Mylan Facility Over Quality and Data Issues

Drug Industry Daily
A A
The FDA cited a Mylan Pharmaceuticals facility for massive quality control problems and inadequate data integrity.

To View This Article:

Login

Subscribe To Drug Industry Daily